Microba Life Sciences Limited (ASX:MAP)
Australia · Delayed Price · Currency is AUD 0.0480
-0.0010 (-2.04%)
Aug 7, 2026, 11:41 AM AEST
Microba Life Sciences Market Cap
Microba Life Sciences has a market cap or net worth of 34.42 million as of August 7, 2026. Its market cap has decreased by -28.14% in one year.
Market Cap
34.42M
Enterprise Value
25.69M
Revenue
14.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
ChartMarket Cap Chart
Since April 5, 2022, Microba Life Sciences's market cap has decreased from 96.03M to 34.42M, a decrease of -64.15%. That is a compound annual growth rate of -21.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 34.42M | -25.63% |
| Dec 31, 2025 | 46.28M | -47.00% |
| Dec 31, 2024 | 87.33M | 8.33% |
| Dec 29, 2023 | 80.61M | -29.31% |
| Dec 30, 2022 | 114.03M | 18.75% |
| Apr 5, 2022 | 96.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 447.11M |
| Healius | 301.35M |
| Monash IVF Group | 272.74M |
| Cryosite | 58.57M |
| Rhythm Biosciences | 32.56M |
| INOVIQ | 27.45M |
| BCAL Diagnostics | 24.33M |
| ImExHS | 16.49M |